Literature DB >> 19382343

Gastrointestinal symptoms in patients with liver cirrhosis are linked to impaired quality of life and psychological distress.

Eva Fritz1, Johann Hammer.   

Abstract

INTRODUCTION: The factors that lead to an impaired quality of life (QoL) in patients with liver cirrhosis are incompletely understood. Gastrointestinal (GI) symptoms are frequent in liver cirrhosis and are known to reduce QoL in GI and non-GI diseases. AIMS: To study the possible association of GI symptoms with QoL and psychological distress in patients with liver cirrhosis.
METHODS: Seventy-five consecutive outpatients with liver cirrhosis received validated questionnaires to assess GI symptoms, QoL, anxiety, depression, and neuroticism. GI symptoms were considered as relevant when they occurred often over the last 12 months (more than 3 months total), were at least moderately severe and/or led to consultation of a physician. An association of GI symptoms with QoL and psychological scores was ascertained by logistic regression analysis before and after adjusting for age and sex.
RESULTS: Eighty percent of patients had one or more relevant GI symptoms. Physical component of QoL correlated negatively with Child-Pugh scores (P<0.01), whereas no association between mental component of QoL and Child-Pugh scores was detectable (P=0.4). Both dimensions of QoL decreased significantly with increasing numbers of GI symptoms reported by the patients (physical component: P<0.001; mental component: P<0.01). Number of GI symptoms was also significantly related to poorer anxiety, depression, and neuroticism scores.
CONCLUSION: GI symptoms are linked to QoL and psychological distress in patients with liver cirrhosis.

Entities:  

Mesh:

Year:  2009        PMID: 19382343

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  7 in total

1.  PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis.

Authors:  J S Bajaj; L R Thacker; J B Wade; A J Sanyal; D M Heuman; R K Sterling; D P Gibson; R T Stravitz; P Puri; M Fuchs; V Luketic; N Noble; M White; D Bell; D A Revicki
Journal:  Aliment Pharmacol Ther       Date:  2011-09-19       Impact factor: 8.171

2.  The cognitive profile of depressed patients with cirrhosis.

Authors:  Charmaine A Stewart; Felicity T B Enders; Mary M Mitchell; Donna Felmlee-Devine; Glenn E Smith
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 3.  Gastrointestinal dysfunction in liver cirrhosis.

Authors:  Evangelos Kalaitzakis
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

4.  Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis.

Authors:  Kavish R Patidar; Leroy R Thacker; James B Wade; Melanie B White; Edith A Gavis; Andrew Fagan; Richard K Sterling; Michael Fuchs; Mohammad S Siddiqui; Scott Matherly; Richard T Stravitz; Arun J Sanyal; Puneet Puri; Velimir A Luketic; Jasmohan S Bajaj
Journal:  Dig Dis Sci       Date:  2017-03-03       Impact factor: 3.199

5.  Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients.

Authors:  Katherine C Barboza; Lilian M Salinas; Farhad Sahebjam; Arun B Jesudian; Ilan L Weisberg; Samuel H Sigal
Journal:  Metab Brain Dis       Date:  2016-03-31       Impact factor: 3.584

6.  Risk of depressive disorder following non-alcoholic cirrhosis: a nationwide population-based study.

Authors:  Chin-Lin Perng; Cheng-Che Shen; Li-Yu Hu; Chiu-Mei Yeh; Mu-Hong Chen; Chia-Fen Tsai; Huey-Ling Chiang; Yi-Ping Hung; Vincent Yi-Fong Su; Yu-Wen Hu; Tung-Ping Su; Pan-Ming Chen; Jeng-Hsiu Hung; Chia-Jen Liu; Min-Wei Huang
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

7.  Predictors of health-related quality of life in outpatients with cirrhosis: results from a prospective cohort.

Authors:  Maja Thiele; Gro Askgaard; Hans B Timm; Ole Hamberg; Lise L Gluud
Journal:  Hepat Res Treat       Date:  2013-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.